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TObjective: Spasm remains a potential problem encountered during the use of arterial
grafts in coronary artery bypass surgery. Heme oxygenase plays a role in the control
of arterial vasoreactivity. Heme oxygenase exists in 2 constitutive isoforms (heme
oxygenase 2 and 3) and an inducible isoform (heme oxygenase 1). The aim of our
study was to induce heme oxygenase 1 by using hemin in human internal thoracic
and radial arteries and to evaluate the effect of this induction on the contractility of
these arterial grafts.
Methods: Segments of human arterial grafts obtained from patients undergoing
isolated coronary artery bypass surgery were incubated in organ chambers for 4
hours in the presence of 104 mol/L hemin. Concentration-response curves to
norepinephrine were obtained in control and hemin-treated arterial rings. Heme
oxygenase 1 expression was evaluated by using enzyme-linked immunosorbent
assays and immunohistochemical staining.
Results: The contractility of the arterial rings to norepinephrine was significantly
reduced after incubation with hemin. Zinc protoporphyrin (an inhibitor of heme
oxygenase) reversed the effect of hemin, whereas the inhibitor of nitric oxide
synthase had no effect. The inhibitor of soluble guanylate cyclase blocked the
decrease in contractility induced by hemin. Immunohistochemical staining revealed
a large expression of heme oxygenase 1 in all vascular layers of hemin-treated
internal thoracic artery and radial artery rings. Enzyme-linked immunosorbent assay
studies showed a significant increase in heme oxygenase 1 levels in hemin-treated
internal thoracic artery and radial artery rings.
Conclusion: Hemin caused in vitro induction of heme oxygenase 1 in human internal
thoracic artery and radial artery grafts. This induction resulted in a reduced con-
tractility to norepinephrine, partially through the cyclic guanosine monophosphate–
dependent pathway. This effect was independent from nitric oxide synthesis.
Since the first coronary artery bypass in the 1950s, coronary artery surgery hasevolved considerably. The internal thoracic artery (ITA) has become the graftof choice for all patients. Other arterial grafts have been explored, but
surgeons were initially confronted with problems of spasm and low permeability
rates. These spastic properties were often exacerbated by postoperative high circu-
lating levels of vasoconstrictors (like epinephrine). The radial artery (RA) was first
used by Carpentier and colleagues in 1971 but was rapidly abandoned after a high
rate of postoperative spasm. Its use became viable 10 years later after the introduc-
tion of perioperative antispastic treatment.1 The current trend in coronary surgery is
total arterial revascularization. However, the vasoactive properties of the arterial
grafts have yet to be understood, and the optimal vasodilator agent to be used in
patients subjected to arterial coronary bypass is still to be defined.
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CSP Currently, heme oxygenase (HO) is viewed as playing an
increasingly important role in the regulation of arterial tone,
as well as in cellular protection. HO is a microsomal en-
zyme that breaks down heme to carbon monoxide, biliver-
din, and iron.2 Biliverdin is reduced to bilirubin, a potent
antioxidant,3 and carbon monoxide possesses vasorelaxing
properties.4,5
HO exists in 3 genetically different isoforms: constitu-
tive HO-2 and HO-3, which predominate in physiologic
situations, and inducible HO-1, which is mostly found in
oxidative and inflammatory conditions.
In vitro animal studies indicate that carbon monoxide,
one of the end products of HO, has an important role in the
control of vascular tone.4-6 In vivo animal studies and
studies on cellular cultures have both succeeded in inducing
HO-1 by using oxidative stimuli, hypoxia, or physical
stress.6-13 Other reports have associated HO-1 with the
control of vasoreactivity in animals.14-16 No report has ever
induced HO-1 in human arterial grafts or studied the effect
of HO-1 induction on the contractility of these grafts.
The aim of our study was to induce HO-1 in human ITA
and RA grafts using hemin and to evaluate the effect of
HO-1 induction on the contractility to norepinephrine (NE)
of these human grafts. Immunohistochemical and enzyme-
linked immunosorbent assay (ELISA) studies were used to
document the induction of HO-1.
Materials and Methods
Sampling of Arterial Segments
Human ITAs and RAs were obtained intraoperatively from 20
patients undergoing elective isolated coronary artery bypass sur-
gery. Table 1 shows the clinical characteristics of these patients.
The study was in accordance with the principles outlined in the
Declaration of Helsinki and was approved by the local ethical
committee. All patients gave their informed consent. The RA was
harvested with its pedicle, including the 2 satellite veins. The ITA
was skeletonized with low-intensity electrical cautery. After total
heparinization of the patient (3 mg/kg), a short distal arterial
segment was harvested for the study just before the bifurcation for
the ITA and at the level of the wrist for the RA. No clamping or
Abbreviations and Acronyms
ELISA enzyme-linked immunosorbent assay
GMP  guanosine monophosphate
HO  heme oxygenase
ITA  internal thoracic artery
LNA  Nw-nitro-L-arginine
NE  norepinephrine
NO  nitric oxide
ODQ  1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one
RA  radial artery
ZnPP  zinc protoporphyrinintraluminal dilatation was performed on the vessels during their
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merged in Dulbecco’s modified Eagle’s solution (Life Technolo-
gies) at 4°C, away from any light exposure.
The mean time between harvesting and experimentation was 20
hours. For experimentation, the blood vessels were cleared of the
surrounding adipose tissue under magnification and cut into 3-mm-
long rings. The arterial rings were studied in organ baths. Care was
taken not to traumatize the endothelium. The number of rings
taken from each blood vessel varied from 4 to 10. Only arterial
rings with functional endothelium were retained for this protocol.
Organ Bath Technique
Arterial rings were mounted on 2 stainless-steel hooks in a 20-mL
water-jacketed glass organ bath filled with physiologic Krebs
solution maintained at 37°C. The organ bath experimentation
technique has been described by Chardigny and colleagues.17 The
arterial rings were progressively stretched to the optimal point of
their length-tension relationship to study the isometric tension
response of the vessels independently of their varying diameter.
On the basis of the work of Chardigny and colleagues, the respec-
tive resting tensions were 5 g for the ITA rings and 9 g for the RA
rings.
Vasoreactivity Experimentation Protocol
First, the contractility of the arterial rings was evaluated in the
presence of 102 mmol/L KCl. The arterial rings were rinsed
afterward to their basal tension. Second, the functionality of the
endothelium was verified by means of the endothelium-dependent
relaxing effect of 106 mol/L acetylcholine and 106 mol/L cal-
cium ionophore. Third, a cumulative concentration-response curve
to NE (109 mol/L to 106 mol/L) was realized in 0.5 log-unit
TABLE 1. Clinical characteristics of the patients
Total no. of patients 20
Median age (y) 56
Sex ratio (men/women) 13/7
Risk factors (n)
Smoking 16
Diabetes mellitus 7
Arterial hypertension 9
Dyslipidemia 13
Preoperative treatment (n)
-Blockers 12
Calcium-channel blockers 5
Nitrates 7
ACE inhibitors 8
Anesthetic drugs (n)
Propofol 20
Cisatracurium 20
Fentanyl 20
Aprotinin 20
Type of graft harvested (n)
Internal thoracic artery 17
Radial artery 12
ACE, Angiotensin-converting enzyme.steps. Fourth, after rinsing and stabilization, 4 to 5 arterial rings per
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Ppatient were incubated for 4 hours in the presence of 104 mol/L
hemin. One to 2 control rings per patient were incubated under the
same conditions without hemin. Selective inhibitors of nitric oxide
(NO) synthase (Nw-nitro-L-arginine [LNA] at 104 mol/L), solu-
ble guanylate cyclase (1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-
one [ODQ] at 105 mol/L), and HO (zinc protoporphyrin [ZnPP]
at 105 mol/L) were added separately to 3 hemin-treated rings
during the last 30 minutes of incubation. The incubations and
manipulations were performed in aluminum foil–wrapped organ
chambers in a dark room to avoid any induction of HO-1 by light18
and because the ZnPP was light sensitive. Finally, after incubation,
another concentration-response curve was obtained in the presence
of increasing concentrations of NE (109 mol/L to 106 mol/L).
The concentration-dependent contraction of each arterial ring after
the incubation phase was compared with the maximal contraction
obtained before the incubation. Each arterial ring before the incu-
bation was therefore used as its own control.
At the end of each experiment, one arterial ring from the
hemin-treated group and one arterial ring from the control group
were embedded in OCT (Tissus-Tek, Sakura Finetek) and con-
served at 80°C for immunohistochemical staining. The rest of
the rings (one arterial ring from each group: hemin-treated, LNA-
treated, ODQ-treated, and control groups) were immediately fro-
zen at 80°C for later ELISA studies. For each patient, one
unmanipulated arterial ring (basal group) was stored in Dulbecco’s
modified Eagle’s medium at 4°C during the whole length of
isolated organ experimentation.
Immunohistochemical Studies of HO-1 and HO-2
Immunohistochemical studies were performed with rabbit poly-
clonal antibodies against HO-1 (H105) and HO-2 (H73; StressGen
Biotechnologies). Seven-micrometer transverse serial sections of
OCT-embedded arterial rings were fixed for 10 minutes with
acetone. Slides were hydrated in phosphate-buffered saline, pH 7.4
(Sigma). Endogenous peroxidases were inactivated with 3% H2O2/
H2O for 20 minutes at room temperature (LSAB kit, DAKO
Cytomation). Nonspecific protein-binding sites were saturated for
60 minutes at room temperature with casein solution (Protein
Block Serum-Free, DAKO). Primary polyclonal antibodies against
HO-1 (1/25:8 g/mL) and HO-2 (1/50: 4 g/mL) were diluted in
50 mmol/L Tris-0,1% Tween (Antibody Diluent, DAKO) and
incubated for 90 minutes at room temperature. Thereafter, slides
were rinsed with phosphate-buffered saline–Tween and labeled
with the Labeled Streptavidin Biotin kit (DAKO). Slides were
revealed with diaminobenzidine as substrate and counterstained
with Mayer’s hematoxylin. Negative controls were obtained on
each slide by using a nonspecific isotypical antibody (rabbit IgG
antibody) at the same concentration as the primary antibody.
Quantification of HO-1 With ELISA
A quantitative detection of HO-1 was done with a human HO-1
ELISA kit (StressGen Biotechnologies). Each frozen arterial ring
was extracted with a TisssueLyser (Retsch), 2  2 minutes at 30
Hz, in 300 L of cold extraction buffer (HO-1 ELISA kit) sup-
plemented with complete protease inhibitors (Complete Mini,
Roche Diagnostics). Homogenates were incubated for 1 hour at
4°C and then centrifuged (1000g for 10 minutes at 4°C), and
supernatants were then stored at 80°C. HO-1 protein levels were
The Journal of Thoracicquantified by means of ELISA, as described by the manufacturer.
Soluble proteins were quantified by using the Lowry method
(Protein Assay, BioRad). Results of HO-1 levels were expressed as
nanograms per milligram of soluble proteins.
Drugs
The different drugs were prepared before each experimentation.
NE, acetylcholine, calcium ionophore, LNA, ODQ, and hemin
(bovine hemin chloride) were bought from Sigma, France. Hemin
and ZnPP were prepared as described by Shibahara and cowork-
ers.19 Photosensitive ZnPP was prepared and manipulated in light-
proof containers.
Data and Statistical Analysis
Tension generated by the blood vessels was digitized by using a
computer with IOX software (EMKA Technologies). The results
were expressed as a percentage of maximal initial contraction
induced by NE. The contractility of the arterial rings after treat-
ment with hemin was compared with the contractility of the
control rings and with that of the hemin plus inhibitor–treated
rings.
In each experiment the hemin-treated rings and the control
rings were harvested from the same patient. For all the studied
parameters, n represented the number of patients. Results were
expressed as means  standard error of the mean. Statistical
analysis was performed with the Student t test for paired values or
2-way analysis of variance, followed by a Bonferroni test for
evaluating the effect of treatments. ELISA results were compared
with the Student t test.
Results
Organ Chamber Studies
NE (109 to 106 mol/L) caused concentration-dependent
contractions of ITA and RA rings (Figures 1 and 2); at 106
mol/L, these contractions averaged 3.2  0.5 g and 5.3 
1.4 g, respectively. The incubation of both ITA and RA
segments with the HO-1–inducing substance hemin (104
mol/L) resulted in a significant reduction of the concentration-
dependent contractions to NE. This reduction in contractil-
ity was completely reversed by the HO inhibitor ZnPP
(105 mol/L) in both ITA and RA segments (Figures 1, A,
and 2, A, respectively). Also, the guanylate cyclase inhibitor
ODQ (105 mol/L) significantly reversed the hemin-induced
reduction in contractility in both ITA and RA segments
(Figure 1, B, and 2, B, respectively). The NO synthase
inhibitor LNA (104 mol/L) did not significantly modify the
effect of hemin on the contractions of the ITA (75% 18%
for LNA vs 73%  12% for control, n  3) and RA (69%
 9% for LNA vs 64%  1% for control, n  3) rings.
Immunohistochemical Identification of HO-1
and HO-2
In human ITAs and RAs, HO-1 was detected on all layers of
rings treated with hemin (Figure 3). HO-1 was localized on
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on endothelial cells of the microvasculature. HO-1 was
mildly detected on cells of control ITA and RA rings. The
constitutive HO-2 protein was observed on all arterial cells
of control and hemin-treated rings in both the ITA and RA
Figure 1. A, Effect of hemin on the concentration-dependent
contractions to norepinephrine (NE) in the human internal tho-
racic artery (n  7). Contractility is expressed as a percentage of
initial maximal contraction force (3.2  0.5 g) induced by NE. The
treatment with hemin significantly decreased the contractile ef-
fect of NE (*P < .05); the contractility was restored by zinc
protoporphyrin (ZnPP) to a similar level than that of the control
rings. B, Effect of 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one
(ODQ) on the concentration-dependent contractions to NE in
hemin-treated human internal thoracic artery rings (n  5-6).
Contractility is expressed as a percentage of maximal contrac-
tion (2.2  0.4 g) induced by NE. The addition of ODQ to hemin-
treated rings significantly increased the contractility induced by
NE (*P < .05).groups (Figure 4).
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In ITA rings the levels of soluble proteins were identical in
the different groups studied: 1.10  0.10, 1.06  0.06, and
1.01  0.06 mg/mL, respectively, for the hemin-treated,
Figure 2. A, Effect of hemin on the concentration-dependent
contractions to norepinephrine (NE) in the human radial artery (n 
5). Contractility is expressed as a percentage of initial maximal
contraction force (5.3  1.4 g) induced by NE. Treatment with
hemin significantly decreased the contractile effect of NE (*P <
.05). The inhibition was restored by zinc protoporphyrin (ZnPP) at
a similar level than that of the control rings. B, Effect of the
addition of 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one (ODQ) on
the concentration-dependent contractions to NE in hemin-treated
human RA rings (n  5). Contractility is expressed as a percent-
age of maximal contraction (5.5  1.5 g) induced by NE. The
addition of ODQ to hemin-treated rings significantly increased the
contractility induced by NE (*P < .05, 2-way analysis of
variance).hemin plus ZnPP–treated, and control groups. Figure 5, A,
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the hemin-treated and hemin plus ZnPP–treated ITA groups
compared with those in the control group.
In RA rings, similar to ITA rings, the levels of soluble
proteins were identical in the different groups studied: 1.80 
0.23, 1.73 0.29, and 1.57 0.14 mg/mL, respectively, for
the hemin-treated, hemin plus ZnPP–treated, and control
groups. Figure 5, B, represents HO-1 levels as measured by
means of ELISA in the hemin-treated and hemin plus ZnPP–
treated RA groups compared with those in the control group.
ELISA studies done on unmanipulated arterial segments
stored at 4°C during the time of the experience (basal group)
Figure 3. A, Immunohistochemical detection of heme oxygenase
1 in hemin-treated internal thoracic artery (n  5). Heme oxygen-
ase 1 was detected in all layers of the artery: smooth muscle
cells of the media (a), endothelium (b), and adventitial microves-
sels (c). B, Immunohistochemical detection of heme oxygenase 1
in hemin-treated radial artery (n  5). Heme oxygenase 1 was
detected in all layers of the artery: smooth muscle cells of the
media (d), endothelium (e), and adventitial microvessels (f). Bar
100 m in a and 200 m in d and 20 m in b, c, e, and f.showed a minimal induction of HO-1 in both the ITA and
The Journal of ThoracicRA groups (3.3  0.8 ng/mg soluble proteins and 4.8  1.9
ng/mg soluble proteins, respectively) compared with that
seen in the control group.
The control levels of HO-1 were higher in the RA rings
than in the ITA rings (26.0 5.0 vs 10.9 2.0 ng/g soluble
protein). The relative increase of HO-1 expression by hemin
was higher in RA rings than in ITA rings (1.7-fold vs
1.4-fold, respectively).
Discussion
The major achievement of the present study is the demon-
stration of HO-1 induction in human arteries and its conse-
Figure 4. A, Immunohistochemical detection of heme oxygenase 2
in hemin-treated internal thoracic artery (n 5). Heme oxygenase 2
was detected in all layers of the artery: smooth muscle cells of the
media (a), endothelium (b), and adventitial microvessels (c). B, Im-
munohistochemical detection of heme oxygenase 2 in hemin-treated
radial artery (n  5). Heme oxygenase 2 was detected in all
layers of the artery: smooth muscle cells of the media (a),
endothelium (b), and adventitial microvessels (c). Bar  100
m in a and 200 m in d and 20 m in b, c, e, and f.quences on arterial contractility. Indeed, the incubation of
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Cardiopulmonary Support and Physiology Achouh et al
CSPhuman ITA and RA rings for 4 hours at 37°C with 104
mol/L hemin induced the synthesis of HO-1, as proved by
immunohistochemical and ELISA studies. On immunohis-
tochemical staining, constitutive HO-2, which normally pre-
dominates in the cardiovascular system,2 was found on all
the layers of both the hemin-treated and the control arterial
rings. The induction of HO-1 by hemin was confirmed on
Figure 5. A, Enzyme-linked immunosorbent assay quantification
of heme oxygenase 1 (HO-1) in hemin-treated human internal
thoracic artery rings compared with that in control and hemin
plus zinc protoporphyrin (ZnPP)–treated rings (n  6). Hemin
treatment increased HO-1 production compared with control val-
ues (15.4  3.6 vs 10.9  2.0 ng/mg soluble proteins, respectively;
*P < .05). ZnPP did not change the level of HO-1 production
compared with hemin treatment (13.0  1.8 vs 15.4  3.6 ng/mg
soluble proteins). Control, Control arterial rings; Hemin, hemin-
treated rings; ZnPP, hemin plus ZnPP–treated rings. B, Enzyme-
linked immunosorbent assay quantification of HO-1 in hemin-
treated human radial artery rings compared with that in control
and ZnPP-treated rings (n  5). Hemin treatment increased HO-1
production compared with control values (44.7 7.5 vs 26.0 5.0
ng/mg soluble proteins, respectively; *P < .05). ZnPP did not
change the level of HO-1 production compared with hemin treat-
ment (34.9  8.3 vs 44.7  7.5 ng/mg soluble proteins). Control,
Control arterial rings; Hemin, hemin-treated rings; ZnPP, hemin
plus ZnPP–treated rings.the different layers of the hemin-treated rings.
1578 The Journal of Thoracic and Cardiovascular Surgery ● DecThe mild expression of HO-1 observed in the control
rings might have been related to the conditions of experi-
mentation, the manipulation of the arterial segments during
their harvesting, their conservation conditions, and their
stretching into their resting tension, all of which constitute
elements of physical stress or hypoxia that have been shown
to induce HO-1 in animals.9,20 The storage of arterial seg-
ments at 4°C before manipulation did not induce significant
levels of HO-1 in ITA or RA rings as has been shown by
means of ELISA studies done on the basal groups (unma-
nipulated control rings stored at 4°C during the experimen-
tation period).
On the other hand, most of the study patients were taking
multiple vasoactive medications, such as nitrates, -
blockers, calcium-channel blockers, and angiotensin-con-
verting enzyme inhibitors. This might have been responsi-
ble for an induction of HO-1 in some of these groups or in
a decrease in initial contractility in others. This would not
have influenced our results but only attenuated the statistical
significance of our results because all arterial segments in
one experiment were taken from the same patient.
The basal level and the increase in the production of
HO-1 were higher in RA rings compared with that seen in
ITA rings. Other reports have shown that the production of
NO is superior in ITAs compared with that seen in RAs.21
These differences in the expression of HO-1 might be
related to a more predominant role of HO in the control of
RA tone compared with that seen in the ITA.
Our results constitute the first report illustrating the in
vitro induction of HO-1 by hemin in human isolated arter-
ies. Yoshida and associates11 succeeded in inducing HO
mRNA production in a culture of human macrophages
treated with 105 mol/L hemin for 3 hours. Panchenko and
colleagues12 induced HO-1 in human dermal fibroblast cul-
ture using hypoxia. Terry and coworkers13 stimulated the
production of HO-1 using tumor necrosis factor and inter-
leukin 1 in human endothelial cell culture.
Other studies have shown that hemin induces HO-1
synthesis in animals. Clark and associates22 found that a
4-hour incubation of bovine vascular smooth muscle cells in
the presence of 104 mol/L hemin provided the maximal
induction of HO-1 with the least cellular toxicity. Two years
earlier, Vesely and colleagues23 had shown that the optimal
concentration of hemin for the induction of HO-1 in a rat
myoblast cell culture was less than 2  106 mol/L. We
chose the protocol of incubation in our study on the basis of
these reports. Other authors20,24 were able to induce HO-1
in cultured rat muscular cells by using different stimuli,
such as heavy metals (cadmium and cobalt), hemin, hyp-
oxia, and hyperthermia.
In our study the 4-hour in vitro incubation of human ITA
and RA rings in the presence of 104 mol/L hemin signif-
icantly reduced the contractility to NE. This decrease in
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production of HO-1 confirmed by means of ELISA. This is
the first report showing that HO-1 can reduce contractility in
isolated human arterial grafts. Furthermore, the decrease in
contractility after hemin incubation was completely inhib-
ited by the addition of 105 mol/L ZnPP, which is known to
be a selective inhibitor of HO at this concentration.25,26 The
addition of LNA, a selective inhibitor of NO synthesis, did
not modify the effect of hemin. This suggests that the
decrease in contractility was mediated by an increase in HO
activity and was independent of the NO pathway. The
addition of ODQ, an inhibitor of soluble guanylate cy-
clase,27 significantly reversed the effect of HO-1 induction
on contractility. Therefore the vasorelaxing effect related to
HO induction was mainly mediated by the stimulation of
soluble guanylate cyclase and the resulting production of cy-
clic guanosine monophosphate (GMP). These findings are in
agreement with the results of several other studies.2,16,24,28
Other cyclic GMP–independent pathways might also partici-
pate in the reduction of the contractile response to NE.29,30
In an experiment comparable with ours, Wang and col-
leagues5 incubated rat-tail arteries in the presence of hemin.
They reported a significant reduction in contractility to NE.
As in our study, this effect was completely inhibited by
ZnPP but not by LNA. Caudill and coworkers16 incubated
segments of rat aorta in the presence of sodium arsenite, an
inducer of HO-1. They reported an increase in the produc-
tion of HO-1 mRNA, as well as a decrease in the contrac-
tility of the arterial segments. This latter effect was also
inhibited by the addition of ZnPP. An in vivo animal study6
also showed that hemin induces a decrease in blood pressure
and in vascular tone through the induction of HO-1. The
similarity in the in vitro reactivity caused by HO-1 induc-
tion between the animal studies and the present human
study suggests that if HO-1 was induced in vivo in human
subjects, the hemodynamic consequences might resemble
those described above in experimental animals. Further
future in vivo studies might prove HO-1 induction in human
subjects to be beneficial in the control of hypertension or in
preventing vasospasm in arterial bypass or other vasospastic
diseases.
Conclusion
This study illustrates the induction of HO-1 in human ITA
and RA grafts after in vitro incubation with hemin. The
induction of HO-1 attenuated the contractility in response to
NE. The decrease in contractility was independent of the
NO pathway and at least partially mediated by the stimula-
tion of the cyclic GMP pathway. Further experiments are
needed to identify the cyclic GMP–independent pathways
activated by HO.
Complementary studies need to be undertaken to accel-
erate the induction of HO-1 by using more physiologic
The Journal of Thoracicstimuli than hemin and to study the effect of HO-1 induction
on endogenous vasoactive factors that are found in high
concentrations after cardiopulmonary bypass. A greater ex-
pression of HO-1, induction of HO-1, or both in an arterial
graft before its use might help prevent postoperative spasm
or ameliorate the long-term permeability of these arterial
grafts used in coronary artery surgery.
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